Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Apr 19 04:00PM ET
Dollar change
Percentage change
Index- P/E- EPS (ttm)-4.89 Insider Own4.41% Shs Outstand1.42M Perf Week-6.74%
Market Cap8.49M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float1.31M Perf Month1.64%
Income-5.85M PEG- EPS next Q-0.70 Inst Own10.81% Short Float0.40% Perf Quarter15.89%
Sales15.20M P/S0.56 EPS this Y106.24% Inst Trans-17.54% Short Ratio0.94 Perf Half Y-8.15%
Book/sh10.16 P/B0.61 EPS next Y- ROA-29.56% Short Interest0.01M Perf Year-50.40%
Cash/sh1.09 P/C5.66 EPS next 5Y20.00% ROE-38.09% 52W Range4.75 - 14.80 Perf YTD-4.62%
Dividend Est.- P/FCF- EPS past 5Y56.09% ROI-39.12% 52W High-58.11% Beta1.22
Dividend TTM- Quick Ratio1.05 Sales past 5Y43.42% Gross Margin37.17% 52W Low30.49% ATR (14)0.31
Dividend Ex-Date- Current Ratio1.17 EPS Y/Y TTM54.47% Oper. Margin-50.14% RSI (14)44.34 Volatility2.86% 4.54%
Employees57 Debt/Eq0.08 Sales Y/Y TTM61.46% Profit Margin-38.51% Recom1.00 Target Price19.00
Option/ShortNo / Yes LT Debt/Eq0.04 EPS Q/Q132.46% Payout- Rel Volume0.30 Prev Close6.70
Sales Surprise2.68% EPS Surprise14.05% Sales Q/Q81.05% EarningsNov 20 BMO Avg Volume5.63K Price6.20
SMA20-3.07% SMA50-3.06% SMA200-7.35% Trades Volume1,663 Change-7.46%
Apr-01-24 10:53AM
Mar-25-24 05:00PM
Feb-13-24 10:00AM
Feb-06-24 10:00AM
Jan-23-24 10:00AM
10:30AM Loading…
Jan-17-24 10:30AM
Jan-02-24 09:00AM
Dec-14-23 04:30PM
Nov-16-23 05:00PM
Oct-18-23 09:00AM
Oct-03-23 10:00AM
Sep-28-23 09:00AM
Sep-25-23 11:00AM
Sep-21-23 09:00AM
Sep-13-23 09:30AM
03:26PM Loading…
Aug-31-23 03:26PM
Aug-19-23 06:01AM
Aug-13-23 10:16AM
Aug-10-23 05:00PM
Aug-08-23 09:00AM
Aug-03-23 09:00AM
Aug-01-23 09:00AM
Jun-14-23 09:49AM
Jun-13-23 09:00AM
Jun-08-23 08:30AM
Jun-07-23 09:30AM
May-22-23 11:00AM
May-17-23 04:00PM
May-15-23 04:00PM
May-04-23 01:00PM
10:00AM Loading…
Apr-27-23 05:00PM
Apr-19-23 11:00AM
Apr-09-23 10:25AM
Apr-02-23 08:55AM
Mar-28-23 05:00PM
Mar-21-23 10:30AM
Mar-07-23 12:49PM
Feb-14-23 11:44AM
Jan-11-23 10:00AM
Dec-06-22 10:00AM
Nov-07-22 10:30AM
Nov-02-22 05:00PM
Oct-18-22 09:07AM
Sep-15-22 11:00AM
Aug-24-22 11:00AM
Aug-16-22 11:00AM
Aug-10-22 10:00AM
Aug-08-22 10:00AM
Jul-20-22 10:30AM
Jun-14-22 02:00PM
Jun-13-22 11:00AM
May-24-22 10:30AM
May-11-22 08:15AM
May-10-22 10:30AM
Apr-26-22 10:00AM
Mar-22-22 06:00PM
Mar-21-22 05:00PM
Feb-24-22 10:00AM
Nov-29-21 07:27AM
Nov-18-21 10:00AM
Nov-03-21 08:00AM
Nov-01-21 05:00PM
Aug-26-21 10:00AM
Aug-20-21 05:00PM
Aug-13-21 10:48AM
Aug-12-21 05:00PM
Jul-28-21 10:00AM
Jun-15-21 11:00AM
Jun-08-21 10:30AM
May-20-21 03:15PM
May-14-21 04:30PM
May-10-21 10:30AM
May-05-21 10:14AM
May-04-21 02:41PM
May-03-21 10:41AM
Apr-26-21 11:00AM
Apr-05-21 09:00AM
Mar-31-21 03:15PM
Mar-30-21 09:00AM
Mar-18-21 04:30PM
Mar-03-21 01:00PM
Jan-28-21 09:30AM
Jan-20-21 10:00AM
Dec-10-20 10:15AM
Nov-19-20 03:15PM
Nov-11-20 09:00AM
Oct-06-20 10:00AM
Sep-22-20 10:30AM
Sep-04-20 09:00AM
Aug-20-20 01:00PM
Aug-07-20 09:00AM
Aug-04-20 10:45AM
Precipio, a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.